Business
Cipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Business
Cipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Busin...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Business\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Business\nCanada NewsWire\nMISSISSAUGA, ON, March 4, 2016\n\n\n\nMISSISSAUGA, ON, March 4, 2016 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) (\"Cipher\" or \"the Company\") today announced that Ralph Bohrer has joined the Company in the position of President and General Manager of its U.S. subsidiary. Mr. Bohrer is a seasoned pharmaceutical executive with 30 years of experience in sales and marketing leadership for growing dermatology companies. \n\nPrior to joining Cipher, he was Executive Director, Sales and Marketing of Taro Pharma, a global leader in the development, manufacture and sale of dermatology products. In this role, he was responsible for all aspects of their branded dermatology business unit for Taro Pharmaceutical Industries. Previously, he was Vice President, Sales at Triax Pharmaceuticals (acquired by PreCision Dermatology in 2012), where he led a 60-person team responsible for the promotion and sale of a line of prescription dermatology products, including category leader Locoid® Lipocream and Lotion, Tretin X® and Minocin®.  Mr. Bohrer was also Principal of Ridgeback Associates, a consulting business he founded to provide companies with insight and direction toward specific and measurable sales, marketing, and business development objectives within various pharmaceutical sectors. Prior to Ridgeback, he spent 14 years with Medicis Pharmaceutical in progressively senior positions, including President of Medicis Canada, and Senior Vice President, Sales, where he helped drive sales from inception to more than US$300 million while establishing and directing a 175-person sales organization. Prior to leaving Medicis, he was General Manager of Ascent Pediatrics/Ucyclyd Pharma, the pediatric and orphan drug subsidiaries of Medicis. \n\n\"We're building a fast-growing dermatology business, underpi...